Denmark Biotechnology & Medical Research

Genmab A/S (GMAB)

Track

The most recent insider trading activity at Genmab A/S occurred on February 19, 2026, with a sale of 1,100 shares by Executive Vice President & Chief Financial Officer Anthony Pagano. Prior to this, other sales and proposed sales by directors and officers were noted, with the earliest transaction dating back to March 1, 2024.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: GMAB Exchange: CPH

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Anthony Pagano

Executive Vice President & Chief Financial Officer

1 sale — total 1,991,110 DKK

Sale 19 Feb 2026

Value DKK3,029,783.39 | Price 130.52 | Shares 85,982

Martin Schultz

Member of the Board of Directors

1 sale — total 343,061 DKK

Sale 19 Nov 2025

Value DKK1,818,882.69 | Price 354.21 | Shares 2,513

Klimovsky Judith V

Director

1 sale — total 67,200 USD

Proposed sale 17 Jun 2025

Value US$67,200.00 | Price 51.69 | Shares 1,300

Klimovsky Judith V

Officer

1 sale — total 330,000 USD

Proposed sale 1 Mar 2024

Value US$330,000.00 | Price 275.00 | Shares 1,200

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-02-20	2026-02-19	S Sale	Anthony Pagano Executive Vice President & Chief Financial Officer Officer	85,982 130.52 DKK3,029,783	85,982	130.52	DKK3,029,783
2025-11-19	2025-11-19	S Sale	2.1 Martin Schultz Member of the Board of Directors Executive Director	2,513 354.21 DKK1,818,883	2,513	354.21	DKK1,818,883
2025-06-17	2025-06-17	PrS Proposed sale	Klimovsky Judith V Director Non-Executive Director	80,815 378.04 US$1,578,430	80,815	378.04	US$1,578,430
2024-03-01	2024-03-01	PrS Proposed sale	Klimovsky Judith V Officer Officer	1,200 275.00 US$330,000	1,200	275.00	US$330,000